Scancell Holdings PLC ORD 0.1P

(LSE, Stocks) 
p 13.45 <%= Resources.Global.txtDown %>
Updated 14:40:20
Change % -0.37% Stock price decreasing
Change -0.05 Stock price decreasing
Volume 34,283
High P 13.50
Low P 13.07
Open P 13.07
ISIN GB00B63D3314
Prev close P 13.50
# of shares 384.61M
Market cap 5,173.03M GBX

Scancell Holdings PLC ORD 0.1P
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  13.45 -5.6% Stock price decreasing -8.5% Stock price decreasing -8.2% Stock price decreasing 3.5% Stock price increasing 31.2% Stock price increasing
Powered by TradingView

Company profile

Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. Scancell is exploiting the unrivaled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Scancell's potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Scancell's Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
21 June 2018 15:35:40
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180619.1 - EUROWEB7 - 2018-06-21 16:35:40 - 2018-06-21 15:35:40 - 1000 - Website: OKAY